维普中文期刊产品整合服务
530篇 您的检索式:作者名="ARGANI"
    题名 作者 年代 出处 被引量
1通过TFE-3融合变异体分析Xp11易位癌之间的临床病理关系显示文摘Xp11易位癌包括Xp11易位性肾细胞癌(RCC)、Xp11易位性血管周上皮样细胞肿瘤(PEComa)以及色素性Xp11易位肾癌。在Xp11易位癌中,TFE3与一些不同基因伴侣的融合,从而激活TFE3致癌基因;然而不同的融合变异体对Xp11易位癌的临床病理特点影响尚不清楚。本文使用定制的细菌人工染色体探针来建立TFE3融合基因伴侣,采用原位荧光杂交对60例Xp11易位癌进行分析。5例通过RNA测序进一步分析其融合转录体的特点。60例Xp11易位癌包括47例Xp11易位性RCC、8例Xp11易位性PEComas以及5例色素性Xp11易位肾癌。60例患者中有53例(88%)确定了融合基因伴侣,包括18例SFPQ(PSF)、16例PRCC、12例ASPSCR1(ASPL)、6例NONO及1例DVL2。Argani P Zhong M Reuter V E 魏建国 刘勇 2016临床与实验病理学杂志2016,32,9:13
2肾脏恶性孤立性纤维性肿瘤过表达BCOR:模拟肾脏透明细胞肉瘤显示文摘BCOR是诊断肾脏透明细胞肉瘤(CCSK)的一种敏感且高度特异的标志物。然而,过表达BCOR的成人肾脏肉瘤中有一部分BCOR基因遗传学改变(包括BCOR基因融合或BCOR内部串联重复)却呈阴性,因此被归为不能分类的肾脏肉瘤。作者报道了5例肾脏/肾周未分化肉瘤,鉴于其形态学特征和高表达BCOR,提示需与CCSK进行鉴别,但经过RNA测序证实为恶性孤立性纤维性肿瘤(SFTs)。发病年龄30~62岁,女性3例,男性2例。4例为原发性肾脏肿瘤,1例为肾周肿瘤。5例肿瘤均为富于细胞性、非多形性的未分化肉瘤,具有毛细血管分支,由圆形至卵圆形肿瘤细胞组成,胞质稀少,核规则,染色质均匀分布。5例中均未出现SFTs的典型特征,如浓染的梭形核、明显的胶原沉积或血管外皮瘤样结构。5例BCOR均强阳性。3例CD34阴性,2例CD34仅局灶阳性。随后免疫组化结果发现,5例STAT6均阳性。魏建国(摘译) 方三高(审校) Argani P Kao Y C Zhang L 2019临床与实验病理学杂志2019,35,8:3
3Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis显示文摘Yoshiharu Miyamoto Anirban Maitra Bidyut Ghosh Ulrich Zechner Pedram Argani Christine A. Iacobuzio-Donahue Virote Sriuranpong Tatsuya Iso Ingrid M. Meszoely Michael S. Wolfe Ralph H. Hruban Douglas W. Ball Roland M. Schmid Steven D. Leach 2003Cancer Cell2003,,6:3
4Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions: A Sensitive and Specific Immunohistochemical Assay显示文摘Pedram Argani Priti Lal Brian Hutchinson Man Yee Lui Victor E. Reuter Marc Ladanyi 2003The American Journal of Surgical Pathology2003,,6:2
5TFE3 fusions activate METsignaling by transcriptional upregulation,defining another class oftumors as candidates for therapeutic MET inhibition显示文摘Tsuda M Davis IJ Argani P 2007CancerRes2007,67,3:1
6Vascular compli- cation and Doppler ultrasonographic finding after renal trans- plantation显示文摘Tarzamni M K Argani H Nurifar M 2007Transplant Proc2007,39,4:1
7Xp11translocation renal cell carcinoma in adults:expanded clinical,pathologic,and genetic spectrum显示文摘Argani P Olgac S Tickoo S K 2007Am J Surg Pathol2007,31,8:1
8The PIK3CA gene is mutated with high frequency in human breast cancers显示文摘Bachman KE Argani P Samuels Y 0,,08:1
9Vascular complication and doppler ultrasonographic finding after renal transplantation显示文摘Tarzamni MK Argani H Nurifar M 0,,04:1
10Do clear cell papillary renal cell carcinomas have malignant potential显示文摘Diolombi ML Cheng L Argani P 2015Am J Surg Pathol2015,39,12:1
11Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas:identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)显示文摘Argani P Iacobuzio-Donahue C Ryu B 2001Clin Cancer Res2001,7,:1
12Lipoprotein(a),homocysteine,and retinal arteriosclerosis显示文摘Ghorbanihaghjo A Javadzadeh A Argani H 2008Mol Vis2008,14,9:1
13Expanding the hisologic spectrum of mucinous tubular and spindle cell carcinoma of the kidney显示文摘Fine SW Argani P DeMarzo AM 2006Am J Surg Pathol2006,30,12:1
14Aberrant nuclear immunore- activity for TFE3 in neoplasms with TFE3 gene fusions:a sensitive and specific immunohistochemical assay 显示文摘Argani P Lal P Hutchinson B 2003Am J Surg Pathol2003,27,6:1
15Xp11translocation renal cell carcinoma显示文摘Ross H Argani P 2010Pathology2010,42,4:1
16Effect of L-carnitine on the serum lipoproteins and HDL-C subclasses in hemodialysis patients 显示文摘Argani H Rahbaninoubar M Ghorbanihagjo A 2005Nephron Clin Pratt2005,101,4:1
17Aberrant nuclear immunoreactivity for TFE3in neoplasms with TFE3gene fusions:a sensitive and specific immunohistochemical assay显示文摘Argani P Lal P Hutchinson B 2003Am J Surg Pathol2003,27,6:1
18Molecular definition of breast tumor heterogeneity 显示文摘Shipitsin M Campbell L L Argani P 2007Cancer Cell2007,11,9:1
19Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay 显示文摘ARGANI P LAL P HUTCHINSON B 2003Am J Surg Pathol2003,27,6:1
20Loss of the tight junction protein claudin- 7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast 显示文摘KOMINSKY SL ARGANI P KORZ D 2003Oncogene2003,22,13:1
返回顶部 每页显示:
共27页 首页 上一页 第1页 下一页 末页 /27 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费